Best Practices for Multi-Jurisdictional Product Approvals in North America (FDA and Health Canada)
This guide outlines strategies to align FDA and Health Canada approval pathways, compress timelines, avoid common pitfalls, and ensure compliance…
Quality Management Systems for Regulatory Compliance: A Practical, End‑to‑End Guide
This guide provides a step-by-step roadmap to build and maintain FDA, Health Canada, ISO 13485, and MDSAP-compliant QMS, emphasizing gap…
How to Leverage Regulatory Intelligence to Minimize Compliance Risks in the US and Canada
Leverage regulatory intelligence to track FDA and Health Canada updates, build agile teams, and use technology for proactive compliance, minimizing…
Developing Tailored Regulatory Strategies for Cosmetics in Evolving Global Markets
Tailor cosmetics regulatory strategies for US MoCRA, EU 1223/2009, and Canada by ensuring facility registration, product listing, safety substantiation, bilingual…
Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada
Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis,…
Seeing Around Corners: Leveraging Regulatory Intelligence to Stay Ahead of US and Canadian Compliance Changes
Arora 297 Consultancy offers expert regulatory intelligence and consulting to proactively navigate US and Canadian compliance changes, ensuring timely impact…
How to Build a Customized Regulatory Submission Roadmap for Cosmetic Brands in the US and Canada
This guide outlines how cosmetic brands can build a customized US and Canada regulatory roadmap, covering product classification, MoCRA and…
North American Regulatory Pathways for Natural Health Products: A Practical Roadmap for Canada (NPN/SL) and the U.S. (DSHEA/NDI)
This guide details North American natural health product regulations: Canada requires premarket NPN and Site Licences; the U.S. uses DSHEA's…
From Compliance to Resilience: Building a Global-Ready QMS
This guide outlines building a resilient, global-ready QMS aligned with FDA QMSR, ISO 13485, and MDSAP, emphasizing risk management, CAPA,…
Key Considerations for Strategic Regulatory Consulting in Multi-jurisdictional Pharmaceutical Markets
Strategic multi-jurisdictional pharma regulatory consulting requires tailored plans, harmonized eCTD dossiers, aligned CMC/labeling, and proactive compliance to streamline FDA, Health…
